ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 750721 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 750721; 2) Community: the network communities that were significantly associated with the response to NSC 750721; 3) Molecule: the relationships between components within communities and NSC 750721; 4) MDR: the compounds that were significantly associated with the NSC 750721.

NSC Compound Enrichment Correlation
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0100967765290133 0.14060406
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0100967765290133 -0.04678626
NSC 740 Methotrexate 0.0100967765290133 0.13980475
NSC 740476 Null 0.0100967765290133 0.20029332
NSC 744063 Null 0.0100967765290133 0.51480206
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.0100967765290133 0.12525664
NSC 759178 Pipamperone 0.0100967765290133 0.47240793
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.0100967765290133 0.4614933
NSC 123528 Alanine, 3-[(p-methoxy-.alpha.,.alpha.-diphenylbenzyl)thio]-, hydrate [4:1] 0.0135588245836371 0.48039645
NSC 13151 Null 0.0135588245836371 0.42345289
Total:108  Current:27    [First] [Prev] [Next] [Last]